Table 2. Frequencies of TLR9 single-nucleotide polymorphisms in five BL-cell lines, 15 primary BL tumors and blood samples from 402 healthy individuals.
| Single-nucleotide polymorphism | ||||
|---|---|---|---|---|
|
rs5743836 −1237 T/C |
rs352140 2848 G/A (P545P) |
BL cell lines N |
BL tumors N (%) |
Healthy individuals N (%) |
| T/T | G/G | 1 | 4 (27) | 178 (44) |
| T/T | G/A | 2 | 5 (33) | 165 (41) |
| T/T | A/A | — | 2 (13) | — |
| T/C | G/G | — | — | 1 (0) |
| T/C | G/A | 2 | 1 (7) | 55 (14) |
| T/C | A/A | — | 3 (20) | 5 (1) |
The frequencies of the polymorphisms were statistically not significantly different